Your browser doesn't support javascript.
loading
Targeted Delivery of Miconazole Employing LL37 Fragment Mutant Peptide CKR12-Poly (Lactic-Co-Glycolic) Acid Polymeric Micelles.
Mori, Takeshi; Yoshida, Miyako; Hazekawa, Mai; Ishibashi, Daisuke; Hatanaka, Yoshiro; Kakehashi, Rie; Nakagawa, Makoto; Nagao, Toshihiro; Yoshii, Miki; Kojima, Honami; Uno, Rio; Uchida, Takahiro.
Afiliação
  • Mori T; Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien 9-Bancho, Nishinomiya City 663-8179, Hyogo, Japan.
  • Yoshida M; Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien 9-Bancho, Nishinomiya City 663-8179, Hyogo, Japan.
  • Hazekawa M; Department of Immunological and Molecular Pharmacology, Faculty of Pharmaceutical Science, Fukuoka University, 8-19-1 Nanakuma, Jonan-Ku, Fukuoka City 814-0180, Fukuoka, Japan.
  • Ishibashi D; Department of Immunological and Molecular Pharmacology, Faculty of Pharmaceutical Science, Fukuoka University, 8-19-1 Nanakuma, Jonan-Ku, Fukuoka City 814-0180, Fukuoka, Japan.
  • Hatanaka Y; Osaka Research Institute of Industrial Science and Technology, 1-6-50 Morinomiya, Joto-ku, Osaka City 536-8553, Osaka, Japan.
  • Kakehashi R; Osaka Research Institute of Industrial Science and Technology, 1-6-50 Morinomiya, Joto-ku, Osaka City 536-8553, Osaka, Japan.
  • Nakagawa M; Osaka Research Institute of Industrial Science and Technology, 1-6-50 Morinomiya, Joto-ku, Osaka City 536-8553, Osaka, Japan.
  • Nagao T; Osaka Research Institute of Industrial Science and Technology, 1-6-50 Morinomiya, Joto-ku, Osaka City 536-8553, Osaka, Japan.
  • Yoshii M; Osaka Research Institute of Industrial Science and Technology, 1-6-50 Morinomiya, Joto-ku, Osaka City 536-8553, Osaka, Japan.
  • Kojima H; Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien 9-Bancho, Nishinomiya City 663-8179, Hyogo, Japan.
  • Uno R; Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien 9-Bancho, Nishinomiya City 663-8179, Hyogo, Japan.
  • Uchida T; Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Mukogawa Women's University, 11-68 Koshien 9-Bancho, Nishinomiya City 663-8179, Hyogo, Japan.
Int J Mol Sci ; 22(21)2021 Nov 08.
Article em En | MEDLINE | ID: mdl-34769486
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candida albicans / Candidíase / Sistemas de Liberação de Medicamentos / Peptídeos Catiônicos Antimicrobianos / Nanopartículas / Copolímero de Ácido Poliláctico e Ácido Poliglicólico / Miconazol Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candida albicans / Candidíase / Sistemas de Liberação de Medicamentos / Peptídeos Catiônicos Antimicrobianos / Nanopartículas / Copolímero de Ácido Poliláctico e Ácido Poliglicólico / Miconazol Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão